BrainSpace

BrainSpace

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.2M

Overview

BrainSpace is a private, pre-revenue medical device startup developing an automated system for managing cerebrospinal fluid (CSF) drainage in hospital settings. Their core product, the Intellidrop, aims to replace labor-intensive manual methods with a precise, automated, and data-generating platform, targeting improved clinical efficiency, patient experience, and data collection for research. The company is positioned to address a significant global need in neurocritical care, with a seasoned leadership team combining medtech commercialization, engineering, and clinical expertise.

Traumatic Brain InjuryHemorrhagic StrokeHydrocephalusNeurological Critical Care

Technology Platform

The Intellidrop platform integrates continuous CSF pressure sensing, robotic precision for drainage control, and closed-loop automation software ('Physical AI') to manage intracranial pressure. It includes a wearable transducer and generates autonomously annotated, high-frequency multimodal data for clinical use and research.

Funding History

1
Total raised:$3.2M
Seed$3.2M

Opportunities

The global need for acute CSF management creates a large addressable market driven by TBI, stroke, and an aging population.
Automating a labor-intensive process offers strong value to hospitals through nursing efficiency gains, potential reduction in ICU length of stay, and cost savings.
The platform's data-generation capability creates a secondary opportunity for AI-driven research and discovery in brain health.

Risk Factors

Key risks include regulatory delays in obtaining FDA clearance, challenges in proving clinical outcome superiority to drive adoption in a conservative field, and establishing a clear reimbursement pathway.
Competition from large, established medtech companies and the technical challenge of ensuring flawless system reliability in the complex ICU environment are also significant.

Competitive Landscape

The primary competition is the entrenched standard of care: manual external ventricular drains (EVDs) and lumbar drainage systems from companies like Integra LifeSciences (external drainage and monitoring) and Medtronic. BrainSpace's automation and data features represent a disruptive approach. Other startups may be exploring smart drainage, but BrainSpace appears to have a first-mover advantage with a fully integrated system.